The acquisitions of GlobalMed and Schauenburg‐Truplast are expected to boost the capabilities of Molded Devices in medical device production
MDI has acquired GlobalMed and Schauenburg‐Truplast from Schauenburg Hose Technology. (Credit: Luiz Giaquini from Pixabay)
US-based plastic components manufacturer Molded Devices (MDI) has acquired medical tubing and extrusion businesses GlobalMed (Canada) and Schauenburg‐Truplast (China) (together, GlobalMed) from Schauenburg Hose Technology.
The financial terms of the deal were not disclosed.
Based in Ontario, Canada, GlobalMed is a pure-play medical tubing and extrusion producer. It provides original equipment manufacturers (OEMs) of medical devices with clinical services in fields like anaesthesia, ventilation, respiratory care, surgery, and sleep apnea.
GlobalMed maintains offices and production facilities in Guangzhou in China and Trenton in Ontario.
Molded Devices president and CEO Gregg Tobin said: “The combination of GlobalMed with MDI further deepens our capabilities for medical device OEMs in line with our global growth strategy.
“Our current expertise in various molding technologies combined with GlobalMed’s extrusion expertise in the design, development, and production of highly engineered extrusions for specialized medical applications and devices will allow us to provide an expanded set of injection moulding, extrusion, design, development, and assembly capabilities to our customers around the world.”
Molded Devices is a portfolio company of private equity firm TruArc Partners. It produces injection moulding, blow moulding, tube extrusion, dip coating, and dip moulding.
The business also offers value-added services like clean room assembly for the production of medical devices, product research and development, and support in engineering and tooling.
Schauenburg Technology, which is based in Germany, is a provider of plastic hose technology.
Schauenburg Technology CEO Marc Georg Schauenburg said: “GlobalMed has experienced an attractive growth trajectory over the past 20 years, becoming a globally recognised player in the medical OEM sector.”